Complete Up To Date Information about Spectam Injectable.
NADA Number: 093-483 | |
| Proprietary Name |
Spectam® Injectable |
|---|---|
| Sponsor |
Teva Animal Health, Inc. |
| Sponsor Address |
3915 South 48th Street Ter. St. Joseph, MO 64506 USA |
| Ingredients |
Spectinomycin Hydrochloride Pentahydrate |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Intramuscular |
| Dose Form |
Liquid |
| Drug Form |
Liquid |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
522.2120 Spectinomycin injection. Specifications: Each milliliter of the drug contains the following amount of spectinomycin activity from spectinomycin dihydrochloride pentahydrate: 100 milligrams. The quantity of spectinomycin referred to in this section refers to the equivalent weight of base activity for the drug. Conditions of use: Dogs Amount: It is administered as spectinomycin dihydrochloride pentahydrate intramuscularly at a dosage level of 2 milligrams to 5.0 milligrams per pound of body weight twice daily. Treatment may be continued for 4 days. Indications: For treatment of infections caused by gram-negative and gram-positive organisms susceptible to spectinomycin. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |
| Tolerances |
A tolerance of 0.1 part per million (ppm) for negligible residues of spectinomycin in uncooked edible tissues of chickens and turkeys is established. A tolerance of 4 ppm for parent spectinomycin (marker residue) in kidney (target tissue) and 0.4 ppm for parent spectinomycin in cattle muscle in cattle is established. |